复旦张江(01349)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01349 复旦张江

未开盘 03-13 16:08:18

3.060

+0.030

+0.99%

最高3.070	最低3.020	成交量55.80万
今开3.040	昨收3.030	日振幅1.65%
总市值31.73亿	流通市值9.98亿	总股本10.37亿
成交额169.85万	换手率0.17%	流通股本3.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01349","market":"HK","secType":"STK","nameCN":"复旦张江","latestPrice":3.06,"timestamp":1773389298937,"preClose":3.03,"halted":0,"volume":558000,"delay":0,"changeRate":0.009900990099009984,"floatShares":326000000,"shares":1036999999,"eps":-0.17010852968122345,"marketStatus":"未开盘","change":0.03,"latestTime":"03-13 16:08:18","open":3.04,"high":3.07,"low":3.02,"amount":1698490,"amplitude":0.016502,"askPrice":3.06,"askSize":40000,"bidPrice":3.03,"bidSize":74000,"shortable":0,"etf":0,"ttmEps":-0.07484775305973833,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773624600000},"marketStatusCode":0,"adr":0,"listingDate":1029168000000,"exchange":"SEHK","adjPreClose":3.03,"nav":14475,"aum":448017213600,"dividendRate":0.010458,"bidAskSpread":0,"openAndCloseTimeList":[[1773365400000,1773374400000],[1773378000000,1773388800000]],"volumeRatio":0.545347927999516,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688505","market":"SH","secType":"STK","nameCN":"复旦张江","latestPrice":8.11,"timestamp":1773385200000,"preClose":8.17,"halted":0,"volume":3438700,"delay":0,"premium":"-66.73"}},"requestUrl":"/m/hq/s/01349","defaultTab":"news","newsList":[{"id":"2618931557","title":"复旦张江03月10日获主力加仓43.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618931557","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618931557?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:15","pubTimestamp":1773130509,"startTime":"0","endTime":"0","summary":"03月10日, 复旦张江股价涨1.32%，报收3.07元，成交金额314.8万元，换手率0.31%，振幅1.98%，量比0.70。复旦张江今日主力资金净流入43.1万元，上一交易日主力净流入49.8万元。该股近5个交易日上涨4.07%，主力资金累计净流入92.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入85.5万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161521a45de5f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161521a45de5f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01349","BK1191"],"gpt_icon":0},{"id":"2617924775","title":"复旦张江盘中异动 急速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617924775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617924775?lang=zh_cn&edition=full","pubTime":"2026-03-05 09:45","pubTimestamp":1772675101,"startTime":"0","endTime":"0","summary":"2026年03月05日早盘09时45分，复旦张江股票出现异动，股价急速拉升5.07%。截至发稿，该股报3.110港元/股，成交量28.6万股，换手率0.09%，振幅3.72%。资金方面，该股资金流入44.253万港元，流出26.165万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。复旦张江股票所在的生物技术行业中，整体涨幅为1.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030509450197a819f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030509450197a819f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01349","BK1191"],"gpt_icon":0},{"id":"1151545081","title":"复旦张江（01349）2月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1151545081","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151545081?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:56","pubTimestamp":1772441784,"startTime":"0","endTime":"0","summary":"上海复旦张江生物医药股份有限公司于2026年3月2日发布最新股份变动月报表，报告期覆盖2026年2月。公告显示，期间公司注册股本及已发行股份均未发生变化，各类股本数量保持稳定。报告期内，公司H股已发行股份数维持在326,000,000股，A股已发行股份数仍为710,572,100股。公告并无新增发行、股份购回或注销，以及期权激励等变动记录。公司声明已遵守香港联交所《上市规则》有关公众持股量要求，并确认截至本月底符合相关规定。公告由公司秘书薛燕签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"gpt_icon":0},{"id":"2616858743","title":"港股异动 | 复旦张江(01349)跌超4% 去年同比盈转亏约1.57亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616858743","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616858743?lang=zh_cn&edition=full","pubTime":"2026-03-02 15:19","pubTimestamp":1772435941,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复旦张江(01349)跌超4%，截至发稿，跌4.15%，报3港元，成交额752.2万港元。消息面上，2月27日，复旦张江公布2025年业绩快报，营业收入约6.86亿元，同比减少3.33%；归属于上市公司股东的净亏损约1.57亿元，同比盈转亏。报告期内，集团生产经营正常，主要上市销售药品种类未发生变化。由于盐酸多柔比星脂质体注射液被纳入国家集采目录，公司产品里葆多®未获中选，依据相关集采规则以及市场竞争格局的改变，公司于报告期内相应调整里葆多®销售策略，包括但不限于自2025年5月1日起梯度下调其市场零售价格，导致其利润率相应下降。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01349","VT","VXUS","BK4588","688505","BK4585","BK0239"],"gpt_icon":0},{"id":"2616454728","title":"每周股票复盘：复旦张江（688505）净利亏损1.57亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2616454728","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616454728?lang=zh_cn&edition=full","pubTime":"2026-03-01 03:00","pubTimestamp":1772305238,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，复旦张江报收于8.68元，较上周的8.62元上涨0.7%。本周，复旦张江2月25日盘中最高价报8.76元。本周关注点来自业绩披露要点：复旦张江2025年归属净利润亏损1.574亿元，同比减少496.23%。公司公告汇总复旦张江2025年度业绩快报公告上海复旦张江生物医药股份有限公司发布2025年度业绩快报，营业总收入685,797,316元，同比下降3.33%；营业利润-155,402,230元，同比大幅下滑6,591.74%；归属于母公司所有者的净利润为-157,439,498元，同比下降496.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100001126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","01349","BK0239","BK1191"],"gpt_icon":0},{"id":"1136304914","title":"上海复旦张江生物医药股份有限公司2025年度营收6.86亿元，经调整净利润-1.84亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136304914","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136304914?lang=zh_cn&edition=full","pubTime":"2026-02-27 18:36","pubTimestamp":1772188575,"startTime":"0","endTime":"0","summary":"根据公告，2025年度公司实现营收约6.86亿元，同比下降3.33%。经调整净利润为-1.84亿元，同比下降3,680.51%。公告显示，公司在报告期内持续加大研发投入，约为3.58亿元，占营收比重超过50%。研发费用的增加以及核心产品里葆多价格调整，导致本期利润贡献明显下降，是公司整体业绩承压的主要原因。公司核心产品里葆多在报告期内由于未能进入集采中选名单，采取了梯度下调市场零售价格等策略，直接影响了其利润贡献。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"gpt_icon":0},{"id":"2614949839","title":"复旦张江发布2025年度业绩快报，亏损1.574亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614949839","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614949839?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:51","pubTimestamp":1772185888,"startTime":"0","endTime":"0","summary":"证券之星消息，复旦张江近日即将发布2025年年报，根据2月27日发布的业绩快报，归属净利润亏损1.574亿元，同比减少496.23%。报告期内本集团研发投入约人民币 3.58 亿元。销售策略，导致该产品的利润贡献与上年同期相比减少约人民币 1 亿元。同时，本集团积极推动研发项目进展，研发费用较上年同期增加约人民币 4,400 万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700030187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","BK0239","BK1191","01349"],"gpt_icon":0},{"id":"1174397883","title":"上海复旦张江（01349）1月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1174397883","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174397883?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:06","pubTimestamp":1771931214,"startTime":"0","endTime":"0","summary":"上海复旦张江生物医药股份有限公司于2026年2月24日披露2026年1月股份变动月报表，显示截至1月31日，公司已发行H股（01349）总数维持在326,000,000股，A股（上海证券交易所科创板：688505）总数继续保持710,572,100股，均与上月底持平。\n公司注册股本持续为人民币103,657,210元，其中H股注册股本人民币32,600,000元，A股注册股本人民币71,057,210元。报告期内未发生新增发行、购回、注销或库存股变动，也无股份期权和股权激励计划的进展披露。\n公司同时确认，截至1月底符合香港联交所有关最低公众持股量的要求。公告由公司秘书薛燕签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01349"],"gpt_icon":0},{"id":"2610959230","title":"复旦张江02月11日主力净流出37.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2610959230","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610959230?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:15","pubTimestamp":1770797738,"startTime":"0","endTime":"0","summary":"02月11日, 复旦张江股价跌2.40%，报收3.25元，成交金额789.0万元，换手率0.73%，振幅4.20%，量比0.53。复旦张江今日主力资金净流出37.1万元，上一交易日主力净流入228.9万元。该股近5个交易日上涨3.49%，主力资金累计净流入66.4万元；近20日主力资金累计净流入188.7万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161823a6ee0b38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161823a6ee0b38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01349"],"gpt_icon":0},{"id":"2610763721","title":"复旦张江：更换持续督导保荐代表人","url":"https://stock-news.laohu8.com/highlight/detail?id=2610763721","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610763721?lang=zh_cn&edition=full","pubTime":"2026-02-09 20:08","pubTimestamp":1770638933,"startTime":"0","endTime":"0","summary":"证券日报网讯2月9日，复旦张江发布公告称，公司首次公开发行股票并在科创板上市项目（以下简称“本项目”）的保荐机构为国泰海通证券股份有限公司（以下简称“国泰海通”），本项目法定持续督导期间为2020年6月19日至2023年12月31日，郑干国先生、陈恒瑞先生为本项目持续督导期间的保荐代表人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602093645633736.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","01349","BK1191","688505"],"gpt_icon":0},{"id":"2609521885","title":"复旦张江公布国际专利申请：“一种蒽环类化合物及其制备方法、中间体和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2609521885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609521885?lang=zh_cn&edition=full","pubTime":"2026-02-08 05:39","pubTimestamp":1770500362,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示复旦张江（688505）公布了一项国际专利申请，专利名为“一种蒽环类化合物及其制备方法、中间体和应用”，专利申请号为PCT/CN2025/112113，国际公布日为2026年2月5日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来复旦张江已公布的国际专利申请1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.78亿元，同比增15.13%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01349","BK1191","BK0239","688505"],"gpt_icon":0},{"id":"2609632452","title":"智通AH统计|2月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2609632452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609632452?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:15","pubTimestamp":1770279306,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止2月5日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为815.25%、354.93%、295.40%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-11.82%、-2.30%、1.62%。其中金风科技、金隅集团、中石化油服的偏离值位居前三，分别为21.73%、19.04%、18.76%；另外，浙江世宝、钧达股份、长飞光纤光缆的偏离值位居后三，分别为-41.23%、-39.46%、-26.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01057","02465","03143","399300","01528","09989","06690","01033","00638","HPAD.SI","LU0650527681.SGD","06869","02579","06031","02628","06613","03678","03606","IE00BGHQDM52.EUR","02009","03145","02691","PAImain","02865","LU2279701549.SGD","02883","00553","00323","09696","03750","01108","00187","02318","IE00B3M56506.USD","01349","00042","00038","82318","02338","00300","159982","BK1523","02359","01276","03968","02208","PNGAY","601318","02218"],"gpt_icon":1},{"id":"2608689675","title":"复旦张江02月02日主力净流出21.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608689675","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608689675?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020134,"startTime":"0","endTime":"0","summary":"02月02日, 复旦张江股价跌5.23%，报收3.08元，成交金额710.9万元，换手率0.70%，振幅4.92%，量比0.81。复旦张江今日主力资金净流出21.7万元，上一交易日主力净流入5.2万元。该股近5个交易日下跌5.52%，主力资金累计净流出161.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出204.7万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161826a6c97226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161826a6c97226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01349"],"gpt_icon":0},{"id":"2608360038","title":"港股异动 | 复旦张江(01349)盘中跌4% 预计2025年由盈转亏最多1.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360038","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608360038?lang=zh_cn&edition=full","pubTime":"2026-02-02 11:11","pubTimestamp":1770001874,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复旦张江盘中跌4%，截至发稿，跌3.69%，报3.13港元，成交额371.59万港元。消息面上，复旦张江公布，集团预计截至2025年12月31日止年度将取得未经审核的归属于母公司所有者的净亏损约为人民币1.2亿元至1.8亿元，2024年同期净利润为人民币3973.39万元；未经审核的归属于母公司所有者的扣除非经常性损益的净亏损约为人民币1.4亿元至2亿元，2024年扣除非经常性损益的净利润为人民币514.52万元。期内研发投入约3.5亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VT","BK0239","BK4585","01349","BK4588","BK1191","688505"],"gpt_icon":0},{"id":"2608896737","title":"荣昌生物、科兴制药、君实生物等多家创新药企2025业绩战况如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2608896737","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608896737?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:25","pubTimestamp":1769999139,"startTime":"0","endTime":"0","summary":"1月30日，包括荣昌生物、科兴制药、君实生物、百利天恒、复旦张江等多家创新药企业发布2025年业绩预告，那么2025年这些药企战绩如何？而科兴制药更是预计，2025年归母净利润同比增长328.83%至455.89%，为1.35亿元至1.75亿元。科兴制药表示，创新药管线突破奠定业绩增长基础。与荣昌生物、科兴制药的强势增长不同，百利天恒、复旦张江等则面临不同程度的业绩压力，但各有应对与布局。各家创新药企业的业绩表现，背后是2025年国产创新药行业的结构性改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104016a6c84b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104016a6c84b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1574","BK1583","09995","LU2328871848.SGD","01877","BK1161","01349","06978","BK1191","BK1515"],"gpt_icon":0},{"id":"2608535488","title":"复旦张江2025年业绩预告，攻坚ADC与光动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2608535488","media":"和讯网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608535488?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:17","pubTimestamp":1769998622,"startTime":"0","endTime":"0","summary":"1月30日晚间，复旦张江发布2025年年度业绩预告。公告显示，公司当期业绩虽面临短期压力，但在创新药研发领域持续加码，ADC与光动力药物管线进展显著，为长期发展筑牢技术壁垒。研发投入的持续加大是复旦张江当期业绩承压的重要原因之一，公告披露，2025年其研发投入约3.5亿元，研发投入占营业收入比例持续上升，资源重点投向ADC与光动力药物等前沿治疗领域，多项核心项目取得关键进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202102907a6c83f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202102907a6c83f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01349"],"gpt_icon":0},{"id":"2607014795","title":"复旦张江(01349)发盈警 预计2025年度归母净亏损约1.2亿至1.8亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607014795","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607014795?lang=zh_cn&edition=full","pubTime":"2026-01-30 19:19","pubTimestamp":1769771965,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复旦张江 发布公告，集团预计截至2025年12月31日止年度将取得未经审核的归属于母公司所有者的净亏损约为人民币1.2亿元至1.8亿元;未经审核的归属于母公司所有者的扣除非经常性损益的净亏损约为人民币1.4亿元至2亿元。报告期内集团研发投入约人民币3.5亿元。与去年同期相比，该产品对集团的利润贡献同比减少约人民币1亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01349","BK0239","688505","BK1191"],"gpt_icon":0},{"id":"2607039496","title":"复旦张江（688505）披露盐酸氨酮戊酸口服溶液用粉末获上市申请受理通知书，1月29日股价下跌0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607039496","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607039496?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:22","pubTimestamp":1769700133,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，复旦张江报收于8.74元，较前一交易日下跌0.68%，最新总市值为90.6亿元。该股当日开盘8.81元，最高8.86元，最低8.71元，成交额达4885.71万元，换手率为0.78%。近日，上海复旦张江生物医药股份有限公司全资子公司泰州复旦张江药业有限公司收到国家药品监督管理局签发的《受理通知书》，盐酸氨酮戊酸口服溶液用粉末用于成人恶性高级别脑胶质瘤患者术中恶性组织可视化的药物上市申请已获受理。该事项对公司近期业绩无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01349","688505","BK0239","BK1191"],"gpt_icon":0},{"id":"2607700883","title":"复旦张江最新公告：盐酸氨酮戊酸口服溶液用粉末用于脑胶质瘤手术可视化获得药物上市申请受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607700883","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607700883?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:41","pubTimestamp":1769679682,"startTime":"0","endTime":"0","summary":"复旦张江(688505.SH)公告称，公司全资子公司泰州复旦张江药业有限公司收到国家药品监督管理局核准签发的《受理通知书》，盐酸氨酮戊酸口服溶液用粉末用于成人恶性高级别脑胶质瘤患者术中恶性组织可视化的药物上市申请获得受理。该药物未来如能获批上市，将进一步丰富公司的产品线，增强公司整体竞争力。但药品上市注册批件取得的时间和结果具有不确定性，该药物上市申请获得受理对公司近期业绩不会产生重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900030099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","01349","688505","BK1191"],"gpt_icon":0},{"id":"2606714583","title":"复旦张江01月28日主力净流出186.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606714583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606714583?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:16","pubTimestamp":1769588170,"startTime":"0","endTime":"0","summary":"01月28日, 复旦张江股价跌2.45%，报收3.19元，成交金额743.2万元，换手率0.70%，振幅4.59%，量比1.09。复旦张江今日主力资金净流出186.8万元，上一交易日主力净流入74.6万元。该股近5个交易日上涨5.28%，主力资金累计净流出133.4万元；近20日主力资金累计净流出139.7万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128163024a45f7ba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128163024a45f7ba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01349"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fd-zj.com","stockEarnings":[{"period":"1week","weight":-0.0065},{"period":"1month","weight":-0.0585},{"period":"3month","weight":0.0588},{"period":"6month","weight":-0.1685},{"period":"1year","weight":0.1972},{"period":"ytd","weight":0.1007}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":-0.066},{"period":"3month","weight":-0.0197},{"period":"6month","weight":-0.035},{"period":"1year","weight":0.0854},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海复旦张江生物医药股份有限公司是一家主要从事生物医药的研究开发、生产制造和市场营销业务的中国公司。该公司的产品包括盐酸氨酮戊酸外用散（商品名：艾拉）和注射用海姆泊芬（商品名：复美达），以及盐酸多柔比星脂质体注射液（商品名：里葆多）。其产品主要用于皮肤性病治疗和抗肿瘤治疗。该公司在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":0.001416},{"month":2,"riseRate":0.461538,"avgChangeRate":0.014509},{"month":3,"riseRate":0.384615,"avgChangeRate":0.026788},{"month":4,"riseRate":0.666667,"avgChangeRate":0.033877},{"month":5,"riseRate":0.5,"avgChangeRate":0.021392},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.036482},{"month":7,"riseRate":0.416667,"avgChangeRate":0.01229},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.050954},{"month":9,"riseRate":0.5,"avgChangeRate":0.011457},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.009053},{"month":11,"riseRate":0.583333,"avgChangeRate":0.018301},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.017318}],"exchange":"SEHK","name":"复旦张江","nameEN":"FUDANZHANGJIANG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复旦张江(01349)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复旦张江(01349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复旦张江,01349,复旦张江股票,复旦张江股票老虎,复旦张江股票老虎国际,复旦张江行情,复旦张江股票行情,复旦张江股价,复旦张江股市,复旦张江股票价格,复旦张江股票交易,复旦张江股票购买,复旦张江股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复旦张江(01349)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复旦张江(01349)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}